Cell Signaling Technology

Phospho-FoxO1 (Ser319) Antibody

#2486 · $362

100
Citing papers
17.3k
Combined citations
Supplier page Find this product

Research areas

Endoplasmic Reticulum Stress and Disease10MicroRNA in disease regulation9Pain Mechanisms and Treatments8Pancreatic function and diabetes8Neuroinflammation and Neurodegeneration Mechanisms7Autophagy in Disease and Therapy7Cancer-related molecular mechanisms research6Nerve injury and regeneration6

Papers citing this product

1
Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice
Scientific Reports·2019·876 cit.·DOI
2
Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury
Journal of Neuroscience·2006·633 cit.·DOI
3
A Peptide c-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance
Journal of Neuroscience·2006·519 cit.·DOI
4
The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis
The Journal of Immunology·2007·509 cit.·DOI
5
Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α
Journal of Neuroscience·2006·484 cit.·DOI
6
Protocadherins mediate dendritic self-avoidance in the mammalian nervous system
Nature·2012·476 cit.·DOI
7
Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases
Experimental & Molecular Medicine·2019·474 cit.·DOI
8
Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer
Journal of Clinical Oncology·2005·409 cit.·DOI
9
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency
Journal of Clinical Investigation·2010·387 cit.·DOI
10
Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies
Journal of Clinical Oncology·2005·364 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.